More Than 1,300 Breast Implant ALCL Cases Diagnosed Worldwide, Including 35 Deaths: Report
Researchers found breast implant ALCL cases worldwide appeared to be exclusively linked to textured implants
Tag Archives: Allergan Biocell
-
-
FDA Warns About Breast Implant Squamous Cell Carcinoma and Lymphoma Risks, Which May Result in Death
Progression of the breast implant squamous cell carcinoma cases has reportedly led to some deaths, according to FDA Safety Communication.
-
Breast Implant ALCL Risk Evaluated in New Study
Allergan faces more than 1,000 breast implant ALCL lawsuits, as researchers continue to work to better understand the risk women face from certain designs
-
Breast Implants Linked to Squamous Cell Carcinoma and Lymphoma in the Capsule, FDA Warns
The FDA is aware of 22 cases of squamous cell carcinoma and lymphomas linked to breast implants, which are unrelated to prior breast implant cancer warnings
-
Breast Implant ALCL Lawsuits Continue To Mount As New Cases of Cancer Diagnosed
Women continue to be diagnosed with BIA-ALCL and other health problems more than two years after Allergan's Biocell breast implants were recalled.
-
Breast Implant Cancer Risks, Health Side Effects Outlined in New FDA Warnings
Requirements include a Boxed Warning about breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and a mandatory patient decision checklist, among others
-
Mentor MemoryShape Siltex Implants Caused Breast Implant Lymphoma, Lawsuit Alleges
-
More Than 600 Allergan Breast Implant Lawsuits and Class Action Claims Pending in Federal MDL
-
Motions to Dismiss Lawsuits Over Allergan Breast Implant Recall To Be Filed and Briefed Early Next Year
-
Breast Implant Risks Among Transgender Community May Be Misdiagnosed, Misunderstood: Report
